Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Structural maintenance of chromosomes protein 4 (SMC4) is a core subunit of the condensin complex—specifically condensin I and II—involved in higher-order chromosome organization, condensation, and segregation during mitosis and meiosis[1][2][3]. SMC4 belongs to the SMC gene family of chromosomal ATPases, characterized by highly conserved nucleotide-binding motifs and complex dimerization[1][2][3]. It pairs with SMC2 to form a heterodimeric V-shaped structure central to condensin holocomplex function, which also includes three additional non-SMC subunits[1]. SMC4 plays critical roles in mitotic chromosome condensation and segregation, maintenance of chromosome structure, DNA repair, and silenced gene expression[3]. SMC4 is essential during development, and its abnormal expression is linked to several cancers—its overexpression promotes tumor cell proliferation and invasion, and is associated with poor prognosis in lung adenocarcinoma and other malignancies[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Structural maintenance of chromosomes protein 4 (SMC4).